Cell Discovery (Mar 2021)

Immune memory in convalescent patients with asymptomatic or mild COVID-19

  • Quan-Xin Long,
  • Yan-Jun Jia,
  • Xin Wang,
  • Hai-Jun Deng,
  • Xiao-Xia Cao,
  • Jun Yuan,
  • Liang Fang,
  • Xu-Rong Cheng,
  • Chao Luo,
  • An-Ran He,
  • Xiao-Jun Tang,
  • Jie-li Hu,
  • Yuan Hu,
  • Ni Tang,
  • Xue-Fei Cai,
  • De-Qiang Wang,
  • Jie Hu,
  • Jing-Fu Qiu,
  • Bei-Zhong Liu,
  • Juan Chen,
  • Ai-long Huang

DOI
https://doi.org/10.1038/s41421-021-00250-9
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 14

Abstract

Read online

Abstract It is important to evaluate the durability of the protective immune response elicited by primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we systematically evaluated the SARS-CoV-2-specific memory B cell and T cell responses in healthy controls and individuals recovered from asymptomatic or symptomatic infection approximately 6 months prior. Comparatively low frequencies of memory B cells specific for the receptor-binding domain (RBD) of spike glycoprotein (S) persisted in the peripheral blood of individuals who recovered from infection (median 0.62%, interquartile range 0.48-0.69). The SARS-CoV-2 RBD-specific memory B cell response was detected in 2 of 13 individuals who recovered from asymptomatic infection and 10 of 20 individuals who recovered from symptomatic infection. T cell responses induced by S, membrane (M), and nucleocapsid (N) peptide libraries from SARS-CoV-2 were observed in individuals recovered from coronavirus disease 2019 (COVID-19), and cross-reactive T cell responses to SARS-CoV-2 were also detected in healthy controls.